S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
S&P 500   3,852.36
DOW   32,920.46
QQQ   311.72
Retirement Plans in 2023: Choosing the Right Account
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Mullen Automotive Stock Gains Momentum On Positive News
Apple’s Earnings, Expectations and Surprises
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
The Bottom Is In For Meta Platforms, Volatility Is Not Over
Cash Holders STILL Aren't Taking Steps to Prepare (Ad)
Exxon Mobil Could Gush To New Highs Very Soon 
Closing prices for crude oil, gold and other commodities
OTCMKTS:EPGNY

Epigenomics - EPGNY Stock Forecast, Price & News

$2.39
0.00 (0.00%)
(As of 02/2/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.39
$2.39
50-Day Range
$2.39
$9.56
52-Week Range
$2.01
$2.39
Volume
N/A
Average Volume
100 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
EPGNY stock logo

About Epigenomics (OTCMKTS:EPGNY) Stock

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.

Receive EPGNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Epigenomics and its competitors with MarketBeat's FREE daily newsletter.

EPGNY Stock News Headlines

Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
EQS-Adhoc: Epigenomics Releases Performance Data on Next Generation Test
Epigenomics Releases Performance Data on Next Generation Test
EQS-News: Epigenomics Releases Performance Data on Next Generation Test
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
DGAP-Adhoc: Epigenomics AG: Capital reduction planned at a ratio of 4 : 1
EPGNY After-Hours Quotes
EPGNY Real-Time Quotes
See More Headlines
Receive EPGNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Epigenomics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:EPGNY
CIK
N/A
Fax
N/A
Employees
32
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Gregory K. Hamilton (Age 52)
    CEO & Member of the Exec. Board
    Comp: $828.44k
  • Dr. Andrew A. Lukowiak Ph.D. (Age 50)
    Pres & Chief Scientific Officer
    Comp: $387.44k
  • Mr. Jens Ravens (Age 52)
    CFO & Member of Exec. Board
  • Frederic Hilke
    Investor Relations Officer
  • Dr. Noel Thomas Doheny
    Chief Exec. Officer of Epigenomics Inc.













EPGNY Stock - Frequently Asked Questions

How have EPGNY shares performed in 2023?

Epigenomics' stock was trading at $9.56 at the start of the year. Since then, EPGNY shares have decreased by 75.0% and is now trading at $2.39.
View the best growth stocks for 2023 here
.

What is Epigenomics' stock symbol?

Epigenomics trades on the OTCMKTS under the ticker symbol "EPGNY."

How do I buy shares of Epigenomics?

Shares of EPGNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Epigenomics' stock price today?

One share of EPGNY stock can currently be purchased for approximately $2.39.

How can I contact Epigenomics?

Epigenomics' mailing address is Geneststrasse 5, Berlin, Berlin 10829. The official website for the company is www.epigenomics.com. The company can be reached via phone at (493) 024-3450.

This page (OTCMKTS:EPGNY) was last updated on 2/3/2023 by MarketBeat.com Staff